Generic Name |
Target |
Source |
Seliciclib |
CDK2; CDK7; CDK9; MCL1 |
Cyclacel Pharmaceuticals Inc |
ON-01910Na |
CDC2; PDGFRB; PLK1 |
Onconova Therapeutics Inc |
SCH-727965 |
CDC2; CDK2; CDK9 |
Schering-Plough Corp |
No Name Given |
AuroraA and AuroraB |
Astrazeneca |
No Name Given |
CDK2, CDK4, CDK6 and FAK |
AstraZeneca |
VX-680.HCl; MK-0457 |
Aurora-1,Aurora-2,Aurora-3;Flt-3;JAK2;RET |
Vertex; Merck |
AG-024322 |
CDC2; CDK2; CDK4 |
Pfizer Inc |
Purvalanol A |
multi-targeted CDK |
The Regents of the Univ. Cali. |
No Name Given |
CDK2, CDK4, CDK6 and FAK |
AstraZeneca |
No Name Given |
PLK-1 |
GSK/Banyu |
No Name Given |
CDK1, CDK2, CDK3 |
AstraZeneca |
BMI-1026 |
CDK1 |
Biomedical Institute (USA) |
PD-171851 |
CDK4 |
Pfizer Inc |
AG-12286 |
CDK |
Agouron/Pfizer |
PHA-680632 |
Aurora A, Aurora B, Aurora C and RTK |
Nerviano, Pfizer |
BI2536 |
PLK-1 |
Boehringer Ingelheim |
H-7 |
CDK7 |
University of California |
Indenopyrazole/Quinazoline |
CDK |
Bristol-Myers Squibb Co |
No Name Given |
PLK-1 |
Smithkline Beecham |
Aurora A Kinase |
AURKA; PRKG1 |
GPC |
ON-01910Na |
PLK1, CDK1 |
Onconova |
No Name Given |
CDKs, FAK |
Astrazeneca |
Berlex |
CDK4 |
Bayer AG |
No Name Given |
PLK-1 |
Smithkline Beecham |
No Name Given |
CDKs FAK |
Astrazeneca |
No Name Given |
WEE1 |
ChemExplorer |
BI-2536 |
PLK1 |
Boehringer Ingelheim Corp |
No Name Given |
Aurora A |
AstraZeneca |
GSK-461364 |
PLK1; PLK3 |
GlaxoSmithKline plc |
No Name Given |
PLK-1 |
Amgen |
HMN-214 |
PLK-1 |
Nippon Shinyaku Co |
No Name Given |
CDKs & FAK |
AstraZeneca |
R-547 |
CDC2; CDK2; CDK4 |
Roche |
No Name Given |
CDKs & FAK |
Astrazeneca |
HMN-214 |
PLK1 |
Nippon Shinyaku |
PD-332991 |
CDK4; CDK6 |
Onyx Pharmaceuticals Inc |
PHA-739358 |
ABL1;AURKA;AURKB;FGFR1;NTRK1;RET |
Nerviano Medical Sciences |
AZD-1152 |
AURKA; AURKB |
AstraZeneca plc |
CDK inhibitor |
CDK |
Johnson & Johnson |
Tozasertib Lactate |
ABL1; AURKA; AURKB; BCR; FLT3; JAK2 |
Vertex Pharmaceuticals Inc |
SNS-032 |
CDK2; CDK7; CDK9; MCL1 |
Bristol-Myers Squibb Co |
BMS-265246 |
CDC2; CDK2 |
Bristol-Myers Squibb Co |
MLN-8054 |
AURKA |
Takeda Pharmaceutical |
Alvocidib |
CDC2; CDK2; CDK4; CDK9 |
US Government |